Clinical Outcomes in Patients with Ischemic versus Non-Ischemic Cardiomyopathy after Angiotensin-Neprilysin Inhibition Therapy

Clinical Outcomes in Patients with Ischemic versus Non-Ischemic Cardiomyopathy after Angiotensin-Neprilysin Inhibition Therapy

Background: The angiotensin receptor-neprilysin inhibitor (ARNI) decreases cardiovascular mortality in patients with chronic heart failure with a reduced ejection fraction (HFrEF). Data regarding the impact of ARNI on the outcome in HFrEF patients according to heart failure etiology are limited. Met...

Full description

Saved in:
Bibliographic Details
Main Authors: Mohammad Abumayyaleh, Christina Pilsinger, Ibrahim El-Battrawy, Marvin Kummer, Jürgen Kuschyk, Martin Borggrefe, Andreas Mügge, Assem Aweimer, Ibrahim Akin
Format: article
Language:EN
Published: MDPI AG 2021
Subjects:
ARNI
ICMP
NICMP
sacubitril/valsartan
tachyarrhythmias
outcomes
Medicine
R
Online Access:https://doaj.org/article/8826516588934d4a9a6bdd8986ee1be1
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items